查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2064188

2026-2034年全球醫療和診斷檢測服務市場規模、佔有率、趨勢和成長分析報告

Global Medical and Diagnostic Laboratory Services Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 284 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球醫療和診斷檢測服務市場預計將從2025年的2,249.5億美元成長至2034年的4,703.2億美元，並預計在2026年至2034年間以8.54%的複合年成長率成長。該市場正因對精準診斷檢測和預防性醫療保健服務的需求不斷成長而顯著擴張。醫療和診斷檢查室為疾病檢測、後續觀察和治療方案製定提供必要的檢測服務。慢性病盛行率上升、醫療保健成本增加以及人們對早期診斷意識的提高是推動市場成長的主要因素。在醫療保健系統中，基於檢查室的診斷對於改善患者預後至關重要。

分子診斷、自動化和實驗室資訊管理系統的技術進步正在提高檢測的準確性和效率。個人化醫療和精準診斷的日益普及為檢測服務供應商創造了新的機會。對傳染病檢查、基因篩檢和常規健康檢查的需求不斷成長，進一步推動了市場成長。對檢測基礎設施的策略性投資也促進了市場發展。

鑑於醫療體系持續關注預防性和個人化醫療，前景極為樂觀。人工智慧、數位病理學和先進的分析技術將提升診斷能力和工作流程效率。新興經濟體醫療服務覆蓋率的擴大將創造更多成長機會。隨著對準確快速診斷的需求不斷成長，檢測服務仍將是醫療服務系統的重要組成部分。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為了解競爭趨勢和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於指定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球醫療與診斷檢測服務市場：按類型分類

  • 市場分析、洞察與預測
  • 診斷影像中心（X光影像、磁振造影（MRI）、超音波影像影像、電腦斷層掃描（CT）、核子醫學掃描術診斷、乳房X光攝影檢查）
  • 醫學檢測服務（臨床化學、血液學、微生物學、免疫學/血清學、分子診斷、病理學、血庫/輸血服務）

第5章：全球醫療保健和診斷檢測服務市場：按支出類型分類

  • 市場分析、洞察與預測
  • 民眾
  • 私人的

第6章：全球醫療與診斷檢測服務市場：按應用領域分類

  • 市場分析、洞察與預測
  • 循環系統
  • 腫瘤學
  • 神經病學
  • 整形外科
  • 胃腸病學
  • 婦科
  • 其他用途

第7章 全球醫療與診斷檢測服務市場：最終用戶性別

  • 市場分析、洞察與預測
  • 男性
  • 女士

第8章 全球醫療與診斷檢測服務市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Laboratory Corporation Of America Holdings
    • Quest Diagnostics Incorporated
    • Eurofins Scientific SE
    • Sonic Healthcare Limited
    • Charles River Laboratories InternationalInc
    • RadNetInc
    • Exact Sciences Corporation
    • Bio-Techne Corporation
    • OPKO HealthInc
    • NateraInc
    • Myriad GeneticsInc
    • NeoGenomicsInc
    • Guardant HealthInc
    • VeracyteInc
    • Invitae Corporation
簡介目錄
Product Code: VMR112118158

The global medical and diagnostic laboratory services market size is expected to reach USD 470.32 Billion in 2034 from USD 224.95 Billion in 2025, growing at a CAGR of 8.54 during 2026-2034.This market is expanding significantly due to growing demand for accurate diagnostic testing and preventive healthcare services. Medical and diagnostic laboratories provide essential testing services for disease detection, monitoring, and treatment planning. Rising prevalence of chronic diseases, increasing healthcare expenditures, and growing awareness of early diagnosis are key factors driving market growth. Healthcare systems are increasingly emphasizing laboratory-based diagnostics to improve patient outcomes.

Technological advancements in molecular diagnostics, automation, and laboratory information management systems are enhancing testing accuracy and efficiency. Growing adoption of personalized medicine and precision diagnostics is creating new opportunities for laboratory service providers. Increasing demand for infectious disease testing, genetic screening, and routine health assessments is further supporting market expansion. Strategic investments in laboratory infrastructure are also contributing to market development.

Future prospects remain highly favorable as healthcare systems continue focusing on preventive and personalized care. Artificial intelligence, digital pathology, and advanced analytics will improve diagnostic capabilities and workflow efficiency. Expanding access to healthcare services in emerging economies will create additional growth opportunities. As demand for accurate and timely diagnostics increases, laboratory services will remain a critical component of healthcare delivery.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Diagnostic Imaging Centers (X-ray Imaging, Magnetic Resonance Imaging (MRI), Ultrasound Imaging, Computed Tomography (CT) Scans, Nuclear Imaging, Mammography)
  • Medical Laboratory Services (Clinical Chemistry, Hematology, Microbiology, Immunology/Serology, Molecular Diagnostics, Pathology, Blood Banking / Transfusion Services)

By Type of Expenditure

  • Public
  • Private

By Application

  • Cardiology
  • Oncology
  • Neurology
  • Orthopedics
  • Gastroenterology
  • Gynecology
  • Other Applications

By End User Gender

  • Male
  • Female

COMPANIES PROFILED

  • Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Sonic Healthcare Limited, Charles River Laboratories International, Inc., RadNet, Inc., Exact Sciences Corporation, Bio-Techne Corporation, OPKO Health, Inc., Natera, Inc., Myriad Genetics, Inc., NeoGenomics, Inc., Guardant Health, Inc., Veracyte, Inc., Invitae Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Diagnostic Imaging Centers (X-ray Imaging, Magnetic Resonance Imaging (MRI), Ultrasound Imaging, Computed Tomography (CT) Scans, Nuclear Imaging, Mammography) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Medical Laboratory Services (Clinical Chemistry, Hematology, Microbiology, Immunology/Serology, Molecular Diagnostics, Pathology, Blood Banking / Transfusion Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES MARKET: BY TYPE OF EXPENDITURE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type Of Expenditure
  • 5.2. Public Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Private Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Orthopedics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Gastroenterology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.7. Gynecology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES MARKET: BY END USER GENDER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User Gender
  • 7.2. Male Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Female Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Type
    • 8.2.2 By Type Of Expenditure
    • 8.2.3 By Application
    • 8.2.4 By End User Gender
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Type
    • 8.3.2 By Type Of Expenditure
    • 8.3.3 By Application
    • 8.3.4 By End User Gender
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Type
    • 8.4.2 By Type Of Expenditure
    • 8.4.3 By Application
    • 8.4.4 By End User Gender
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Type
    • 8.5.2 By Type Of Expenditure
    • 8.5.3 By Application
    • 8.5.4 By End User Gender
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Type
    • 8.6.2 By Type Of Expenditure
    • 8.6.3 By Application
    • 8.6.4 By End User Gender
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL MEDICAL AND DIAGNOSTIC LABORATORY SERVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Laboratory Corporation Of America Holdings
    • 10.2.2 Quest Diagnostics Incorporated
    • 10.2.3 Eurofins Scientific SE
    • 10.2.4 Sonic Healthcare Limited
    • 10.2.5 Charles River Laboratories InternationalInc
    • 10.2.6 RadNetInc
    • 10.2.7 Exact Sciences Corporation
    • 10.2.8 Bio-Techne Corporation
    • 10.2.9 OPKO HealthInc
    • 10.2.10 NateraInc
    • 10.2.11 Myriad GeneticsInc
    • 10.2.12 NeoGenomicsInc
    • 10.2.13 Guardant HealthInc
    • 10.2.14 VeracyteInc
    • 10.2.15 Invitae Corporation